Surgalign Holdings, Inc. Schedules Second Quarter 2020 Earnings Call for August 4, 2020
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced its second quarter 2020 financial results will be released on August 4, 2020, before market open. A conference call will follow at 9:00 a.m. ET, accessible at (877) 383-7419 (U.S.) or (760) 666-3754 (International), using conference ID 8591446. The call will also be available via webcast on Surgalign’s investor website. As a global spine technology company, Surgalign focuses on innovative solutions to enhance surgical outcomes and patient lives, distributing its products in over 50 countries.
- Upcoming financial results release on August 4, 2020, which may provide insights into business performance.
- Focus on innovation in spine technology signals commitment to improving patient outcomes.
- None.
DEERFIELD, Ill., July 27, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced it plans to release financial results from the second quarter 2020 on Tuesday, August 4, 2020, prior to the market open.
Surgalign will host a conference call and audio webcast at 9:00 a.m. ET the same day. The conference call can be accessed by dialing (877) 383-7419 (U.S.) or (760) 666-3754 (International), using conference ID 8591446. The webcast can be accessed through the investor section of Surgalign’s website at surgalign.com/investors/. A replay of the conference call will be available on Surgalign’s website for one month following the call.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company is building off a legacy of high quality and differentiated products, and continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient’s lives. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign, a member of AdvaMed, is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Marquette, MI, and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
Jonathon Singer
Investor and Media Contact
jsinger@surgalign.com
FAQ
When will Surgalign Holdings release its Q2 2020 financial results?
What time is the conference call for Surgalign's Q2 2020 results?
How can I access the webcast for Surgalign Holdings' conference call?
What is Surgalign Holdings focused on in its business operations?
